Description

Sodium Tetradecyl Sulfate (STS) Injection

Overview

Sodium Tetradecyl Sulfate (STS) is an anionic surfactant used primarily as a sclerosing agent in the treatment of varicose veins and vascular malformations. It is known for its effectiveness in sclerotherapy procedures.

Uses

• Sclerotherapy: STS is injected into affected veins to treat small uncomplicated varicose veins in the lower extremities.
• Vascular Malformations: It is also used for certain vascular malformations, promoting vein closure and reducing visibility.

Mechanism of Action

• Endothelial Irritation: Upon injection, STS irritates the endothelium, leading to inflammation.
• Thrombus Formation: This irritation causes clot formation within the vein, resulting in occlusion.
• Fibrous Tissue Development: Over time, the vein is obliterated due to the formation of fibrous tissue, effectively treating the condition.

Dosage and Administration

• Concentration: Typically available in 1% or 3% solutions.
• Dosage: The usual adult dose ranges from 0.5 mL to 2 mL per injection, with a maximum of 10 mL per treatment session.
• Administration: Careful injection technique is crucial to minimize side effects.

Side Effects

• Common: Pain or swelling at the injection site.
• Allergic Reactions: Potential for hives or difficulty breathing.
• Serious Complications: Risk of deep vein thrombosis or pulmonary embolism.

Warnings and Contraindications

• Monitoring: Patients should be closely monitored post-injection for adverse reactions.
• Contraindications: Not recommended for individuals with severe infections, blood clot disorders, or those who are bedridden due to serious illness.
  

  Key Benefits of Sodium Tetradecyl Sulfate Injection

  1. Effective Treatment for Varicose Veins: Sodium tetradecyl sulfate is primarily used to treat small uncomplicated varicose veins in the lower extremities, helping to reduce their size and visibility by inducing clot formation and scar tissue development within the veins.
  2. Minimally Invasive Procedure: The injection is performed under local anesthesia, making it a less invasive alternative compared to surgical options for treating varicose veins. This can lead to quicker recovery times and less postoperative discomfort.
  3. Long-Lasting Results: While not a permanent cure, many patients experience significant improvement in the appearance of their veins and symptom relief following treatment.
  4. Versatile Use: Besides varicose veins, sodium tetradecyl sulfate can be utilized for treating other vascular malformations, making it a versatile option in sclerotherapy.
  5. Cost-Effective: Compared to surgical interventions, sclerotherapy with sodium tetradecyl sulfate is often more affordable, making it accessible for a wider range of patients.

  Key Ingredients in Sodium Tetradecyl Sulfate Injection

  • Sodium Tetradecyl Sulfate: The active ingredient, present in concentrations of 1% (10 mg/mL) or 3% (30 mg/mL), which acts as the sclerosing agent.
  • Benzyl Alcohol: Present in a small quantity (0.02 mL), it serves as a preservative to maintain the sterility of the solution.
  • Dibasic Sodium Phosphate: This ingredient is included to help maintain the pH of the solution, ensuring stability and effectiveness during administration.
  • Water for Injection: The solvent used to dissolve the active ingredients, making the solution suitable for intravenous use.

  Mechanism of Action of Sodium Tetradecyl Sulfate Injection

  Sodium tetradecyl sulfate (STS) acts as an anionic surfactant and sclerosing agent, primarily used in the treatment of varicose veins. Its mechanism of action involves several key processes:

  1. Detergent Action: As a detergent, STS interacts with lipid molecules within the cell membranes of the vein wall. This interaction disrupts the normal structure of the endothelial cells, leading to their destruction and inflammation of the internal lining of the vein.
  2. Intimal Inflammation: Upon injection, STS induces a localized inflammatory response. This inflammation is critical for the subsequent formation of a thrombus (blood clot) within the vein.
  3. Thrombus Formation: The inflammatory response leads to platelet activation and aggregation, resulting in the formation of a thrombus. This clotting process occludes the vein, effectively stopping blood flow through it.
  4. Sclerosis of the Vein: Over time, the combination of endothelial damage and thrombus formation results in the development of fibrous tissue within the vein. This fibrous tissue replaces the normal vein structure, leading to sclerosis (hardening and closure) of the vein, which may be temporary or permanent depending on the treatment and individual response.
  5. Hemostasis: In addition to treating varicose veins, STS can also promote hemostasis in instances of active bleeding, such as in esophageal varices, by inducing smooth muscle spasm and creating mechanical compression through submucosal edema.

  

  Chemical Structure of Sodium Tetradecyl Sulfate

  Sodium tetradecyl sulfate (STS) has a specific chemical structure characterized by its molecular formula and structural components.

  Molecular Formula

  • C14H29NaO4S

  Molecular Weight

  • 316.43 g/mol

  Structural Characteristics

  • Sodium tetradecyl sulfate is the sodium salt of a sulfate ester derived from tetradecanol. It consists of a long hydrocarbon tail (tetradecyl group) and a sulfate group, which contributes to its surfactant properties.

  Structural Representation

  The chemical structure can be represented as follows:

  text

  O
||
CH3-(CH2)12-CH2-O-SO3Na


  In this representation:

  • The long chain (C14) indicates the tetradecyl part.
  • The sulfate group (SO4) is attached to the hydrocarbon chain, with the sodium ion (Na) indicating its salt form.

  Physical Appearance

  Sodium tetradecyl sulfate is typically a white, waxy solid that is soluble in water, alcohol, and ether, with a pH range of 6.5 to 9.0 in a 5% solution.                                                                               

  Historical Uses of Sodium Tetradecyl Sulfate

  1. Development and Introduction: Sodium tetradecyl sulfate was developed in the 1940s as a synthetic detergent. Its surfactant properties were quickly recognized for their potential in medical applications, particularly for sclerotherapy.
  2. Sclerotherapy for Varicose Veins: STS has been widely used as a sclerosing agent to treat varicose veins. The method gained popularity due to its effectiveness in inducing thrombosis and subsequent fibrosis within the veins, which helps reduce their size and visibility.
  3. Treatment of Hemorrhoids: Beyond varicose veins, STS has been utilized in the treatment of hemorrhoids. It acts as an irritant to promote sclerosis in hemorrhoidal tissues, providing relief from symptoms.
  4. Global Adoption: The use of sodium tetradecyl sulfate as a sclerosing solution has been adopted worldwide, with various formulations and concentrations available for clinical use. It has been a staple in phlebology (the study of veins) for decades.
  5. Regulatory and Safety Considerations: While effective, the use of STS has been accompanied by safety concerns, including reports of severe adverse effects. These incidents have led to increased scrutiny and regulation of its use in medical settings.
  6. Modern Applications: Today, sodium tetradecyl sulfate continues to be a preferred agent in sclerotherapy, with ongoing research into its efficacy and safety profile, as well as its applications in treating other vascular conditions.

  Key Precautions for Sodium Tetradecyl Sulfate Injection

  1. Patient Screening: Prior to administration, it is crucial to screen patients for any history of allergies to sodium tetradecyl sulfate or other sclerosing agents. A thorough medical history should be taken to identify any contraindications.
  2. Monitoring for Adverse Reactions: Patients should be monitored closely during and after the injection for any signs of severe allergic reactions, such as difficulty breathing, swelling, or hives. Immediate medical attention should be available in case of anaphylaxis.
  3. Injection Technique: Proper injection technique is essential to minimize complications. The agent should be injected into the affected vein under sterile conditions to prevent infection and ensure the effectiveness of the treatment.
  4. Avoiding Overdose: Adhere to recommended dosages to avoid complications such as thrombosis or tissue necrosis. The maximum dosage should not exceed the established limits.
  5. Post-Procedure Care: Patients should be advised on post-procedure care, including the need to wear compression stockings and avoid strenuous activities for a specified period to promote healing and reduce the risk of complications.
  6. Contraindications: STS should not be used in patients with certain conditions such as severe peripheral vascular disease, active infections, or clotting disorders. A risk-benefit analysis should be conducted for patients with a history of deep vein thrombosis or pulmonary embolism.

  Dietary Restrictions

  While there are no specific dietary restrictions directly associated with the use of sodium tetradecyl sulfate, general dietary considerations may be relevant for patients undergoing sclerotherapy:

  1. Hydration: Patients are encouraged to maintain adequate hydration before and after the procedure to support overall vascular health.
  2. Avoiding Blood Thinners: Patients should consult their healthcare provider regarding the consumption of foods or supplements that may act as blood thinners (e.g., garlic, ginger, ginkgo biloba) prior to the procedure, as these may increase the risk of bleeding.
  3. Healthy Diet: A balanced diet rich in fruits, vegetables, whole grains, and lean proteins can support recovery and overall health. Patients may benefit from avoiding excessive salt, sugar, and processed foods to maintain healthy blood pressure and circulation.
  4. Alcohol Consumption: It may be advisable to limit alcohol intake, as it can affect blood circulation and may interact with medications prescribed post-treatment.

  Interaction with Other Medications

  1. No Severe Interactions: Sodium tetradecyl sulfate has no known severe, serious, or moderate interactions with other drugs. This indicates that it can be used alongside many other medications without significant risk of adverse effects related to drug interactions.
  2. Minor Interactions: There are minor interactions noted, particularly with medications such as mestranol, a synthetic estrogen used in some birth control pills. Patients should inform their healthcare providers about all medications they are taking to assess any potential minor interactions.
  3. Importance of Disclosure: It is crucial for patients to disclose all prescription and over-the-counter medications, as well as any herbal supplements they are using. This allows healthcare providers to evaluate the risk of interactions and adjust treatment plans accordingly.
  4. Monitoring During Treatment: Patients receiving sodium tetradecyl sulfate should be monitored for any unusual reactions, especially if they are taking other medications that may affect blood clotting or vascular health.
  5. Consultation for Changes: Patients should not start, stop, or change the dosage of any medication without consulting their healthcare provider, as this could impact the safety and effectiveness of sodium tetradecyl sulfate treatment.

  Pregnancy

  • Animal studies show risk, but human studies are not available or neither animal nor human studies were done.
  • It is not known whether STS will harm an unborn baby. STS should only be given to a pregnant woman if clearly needed and the benefits outweigh the risks.

  Breastfeeding

  • It is unknown if STS passes into breast milk.
  • International guidelines recommend that breastfeeding be withheld for 2 days after sclerotherapy with STS, although STS is unlikely to adversely affect the breastfed infant.
  • Use caution while breastfeeding. Consult your doctor.

  Dosage

  Sodium Tetradecyl Sulfate is administered as an injectable solution for sclerotherapy, primarily used to treat varicose veins. The recommended dosages are as follows:

  • Concentration: Available in 1% (10 mg/mL) and 3% (30 mg/mL) solutions.
  • Injection Volume:
    • For the 1% solution: 5–20 mg (0.5–2 mL) per injection site.
    • For the 3% solution: 15–60 mg (0.5–2 mL) per injection site.
  • Maximum Dosage:
    • Do not exceed 2 mL per injection site.
    • The total maximum dosage per treatment session should not exceed 10 mL.

  Storage

  Sodium Tetradecyl Sulfate should be stored under the following conditions:

  • Temperature: Store at 20° to 25°C (68° to 77°F), which is considered controlled room temperature.
  • Precautions: Do not use if the solution has precipitated. Ensure that it is kept away from light and stored in a cool, dry place.

  Reviews

  Sodium Tetradecyl Sulfate has mixed reviews from users, particularly regarding its effectiveness and side effects:

  • Average Rating: The average rating is 4.0 out of 10 based on user feedback, indicating a significant number of negative experiences.
  • Positive Experiences: Some users reported effective treatment for varicose veins without adverse reactions.